This microenvironment high in TGF-β signaling has further characterized a poor-prognostic phenotype in colorectal cancer, and preclinical models showed that inhibition of TGF-β stops disease progression in liver metastases from colon cancer (36). This evidence concerns the gene TGFB1 and colonic neoplasm.